Gene: SEPTIN14
Official Full Name: septin 14provided by HGNC
Gene Summary: SEPT14 is a member of the highly conserved septin family of GTP-binding cytoskeletal proteins implicated in membrane transport, apoptosis, cell polarity, cell cycle regulation, cytokinesis, and other cellular functions (Peterson et al., 2007 [PubMed 17922164]).[supplied by OMIM, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14209 | SEPTIN14 Knockout cell line (HEK293) | Human | SEPTIN14 | 1:3~1:6 | Negative | Online Inquiry |
SEPTIN14 Gene Knockout Cell Lines are specialized cellular models engineered to have the SEPTIN14 gene deactivated, allowing researchers to investigate the role and function of this critical gene in various biological processes. The SEPTIN14 gene is part of the septin family of GTP-binding proteins, which are vital for cytoskeletal organization, cell division, and membrane dynamics. By utilizing these knockout cell lines, scientists can examine the consequences of SEPTIN14 deficiency on cellular functions, providing insights into cellular mechanics and signaling pathways.
The key function of these cell lines revolves around the dissection of cellular pathways influenced by SEPTIN14. Mechanistically, the absence of SEPTIN14 can alter the cytoskeletal architecture and disrupt normal cellular processes, allowing researchers to assess ipso facto effects and downstream signaling cascades. This creates invaluable opportunities for studies related to cancer biology, neurodegeneration, and infectious diseases, where septin proteins are increasingly recognized for their roles in pathogen interactions and cellular homeostasis.
The scientific importance of SEPTIN14 Gene Knockout Cell Lines extends to both research and clinical applications. Researchers can utilize these models to uncover alternative functions of septins and their potential as therapeutic targets, while clinicians can translate findings to develop innovative treatment strategies for diseases where SEPTIN14 plays a significant role.
One of the distinct advantages of our SEPTIN14 Gene Knockout Cell Lines is their state-of-the-art gene editing technology, coupled with robust validation processes that ensure high specificity and efficiency. Unlike conventional methods, these cell lines are pre-validated for consistent performance, significantly reducing the time and complexity involved in experimental design.
This product represents an essential tool for researchers and clinicians aiming to extend their understanding of septins in health and disease. By incorporating our SEPTIN14 Gene Knockout Cell Lines into their studies, users can lay the groundwork for groundbreaking discoveries with far-reaching implications in both basic science and therapeutic development.
At our company, extensive expertise in genetic engineering and cell line development underpins our product offerings, ensuring that our clients receive high-quality tools that enhance their research capabilities.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.